Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.1440
-0.0090
(-5.88%)
At close: February 28 at 8:08:56 AM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
168,174
244,486
182,935
213,250
Total Liabilities Net Minority Interest
151,512
116,750
97,717
122,697
Total Equity Gross Minority Interest
16,662
127,736
85,218
90,553
Total Capitalization
51,218
168,385
125,475
130,104
Common Stock Equity
16,662
127,736
85,218
90,553
Capital Lease Obligations
20,852
22,922
24,934
26,662
Net Tangible Assets
16,662
127,736
85,218
90,553
Working Capital
108,299
180,614
105,077
149,933
Invested Capital
57,885
168,385
125,475
130,104
Tangible Book Value
16,662
127,736
85,218
90,553
Total Debt
62,075
63,571
65,191
66,213
Share Issued
26,448.6780
20,263.1160
6,202.4030
5,622.2740
Ordinary Shares Number
26,448.6780
20,263.1160
6,202.4030
5,622.2740
12/31/2020 - 3/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8AW0.MU Ocean Biomedical Inc
0.0965
-3.50%
0M4.F Mersana Therapeutics, Inc.
0.4243
-1.94%
0M4.SG Mersana Therapeutics Inc
0.4769
-1.22%
AT20.F Atara Biotherapeutics, Inc.
6.55
-5.76%
0M4.DU Mersana Therapeutics Inc
0.4706
-5.35%
8AW0.BE Ocean Biomedical Inc
0.0945
-2.07%
8AW0.F Ocean Biomedical, Inc.
0.0860
-3.37%
8AW0.SG Ocean Biomedical Inc
0.0915
+0.55%
NV4.F Cellectar Biosciences, Inc.
0.2800
+6.87%
NV4.MU Cellectar Biosciences Inc
0.2880
+4.35%